Literature DB >> 31040418

Japan responds: stem-cell therapy justified.

Shinji Miyamoto.   

Abstract

Keywords:  Ethics; Policy; Stem cells

Mesh：

Year:  2019        PMID： 31040418     DOI： 10.1038/d41586-019-01364-7

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  The potent effects of Japan's stem-cell policies.

Authors:  David Cyranoski
Journal:  Nature       Date:  2019-09       Impact factor: 49.962

Review 2.  Applying stem cell therapy in intractable diseases: a narrative review of decades of progress and challenges.

Authors:  Anna Pick Kiong Brianna; Ying Pei Ling
Journal:  Stem Cell Investig       Date:  2022-09-30

3.  Multimodal Repair of Spinal Cord Injury With Mesenchymal Stem Cells.

Authors:  Yuan-Huan Ma; Qing-Yue Liang; Ying Ding; Inbo Han; Xiang Zeng
Journal:  Neurospine       Date:  2022-09-30

Review 4.  Mesenchymal stromal cell and bone marrow concentrate therapies for musculoskeletal indications: a concise review of current literature.

Authors:  Christian Eder; Katharina Schmidt-Bleek; Sven Geissler; F Andrea Sass; Tazio Maleitzke; Matthias Pumberger; Carsten Perka; Georg N Duda; Tobias Winkler
Journal:  Mol Biol Rep       Date:  2020-05-25       Impact factor: 2.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.